Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barre syndrome

American Journal of Epidemiology

Volumn 147, Issue 1, 1998, Pages 69-73

  Kinnunen, Esko ^a   Junttila, Outi ^a   Haukka, Jari ^b   Hovi, Tapani ^b  

^a HYVINKÄÄ HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Poliovirus vaccine, oral; Polyradiculoneuritis; Vaccination

Indexed keywords

POLIOMYELITIS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; FINLAND; GUILLAIN BARRE SYNDROME; HEALTH PROGRAM; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POLIOMYELITIS; RISK ASSESSMENT; SCHOOL CHILD; VACCINATION;

EID: 0031963005     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009369     Document Type: Article

References (16)

1. Hurwitz ES, Holman RC, Nelson DB, et al. National surveillance for Guillain-Barré syndrome: January 1978-March 1979. Neurology 1983;33:150-3.
2. Schonberger LB, Bregman DJ, Sullivan-Bolyal JZ, et al. Guillain-Barré syndrome following vaccination in the national influenza immunization program, United States 1976-1977. Am J Epidemiol 1979;110:105-23.
3. Hovi T, Cantell K, Huovilainen A, et al. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet 1986;1:1427-32.
4. Kinnunen E, Färkkilä M, Hovi T, et al. Incidence of Guillain-Barré syndrome during a nationwide oral poliovirus vaccine campaign. Neurology 1989;39:1034-6.
5. Stratton KR, Howe CJ, Johnston RB Jr, eds. Adverse effects associated with childhood vaccines: evidence bearing of causality. Washington, DC: National Academy Press, 1993.
6. Asbury AK. Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol 1981;9(suppl):1-5.
7. Poser CM. Criteria for the diagnosis of the Guillain-Barré syndrome. J Neurol Sci 1981;52:191-9.
8. Kinnunen E, Hovi T, Stenvik M. Outbreak of poliomyelitis in Finland in 1984. Description of nine cases with persisting paralysis. Scand J Infect Dis 1986;18:15-18.
9. Poyry T, Stenvik M, Hovi T. Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland. Appl Environ Microbiol 1988;54:371-4.
10. Cleveland WS, Devlin SJ. Calendar effects in monthly time series: modelling and adjustment. J Am Stat Assoc 1982;77: 520-8.
11. Worseley KJ. Confidence regions and tests for change-point in a sequence of exponential family random variables. Biometrika 1986;73:91-104.
12. Kaplan JE, Schonberger LB, Hurwitz ES, et al. Guillain-Barré syndrome in the United States, 1978-1981: additional observations from the national surveillance system. Neurology 1983;33:633-7.
13. Larsen JP, Kvale G, Nyland H. Epidemiology of the Guillain-Barré syndrome in the county of Hordaland, Western Norway. Acta Neurol Scand 1985;71:43-7.
14. Langmuir AD, Bregman DJ, Kurland LT, et al. An epidemiological and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol 1984;119:841-79.
15. Uhari M, Rantala H, Niemela M. Cluster of childhood Guillain-Barré cases after an oral poliovaccine campaign. Lancet 1989;2:440-1.
16. Rantala H, Cherry JD, Shields WD, et al. Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration and occurrence. J Pediatr 1994;124: 220-3.